Santhera Pharmaceuticals Holding (SPHDF) Gets a Buy from H.C. Wainwright
In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Santhera Pharmaceuticals Holding, with a price target of CHF30.00. The company’s shares closed last Monday at...
Analysts Offer Insights on Healthcare Companies: Santhera Pharmaceuticals Holding (OtherSPHDF) and Reviva Pharmaceuticals Holdings (RVPH)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Santhera Pharmaceuticals Holding (SPHDF – Research Report) and Reviva Pharmaceuticals Holdings (RVPH –...